Compare APA & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APA | FMS |
|---|---|---|
| Founded | 1954 | 1996 |
| Country | United States | Germany |
| Employees | N/A | 108165 |
| Industry | Oil & Gas Production | Misc Health and Biotechnology Services |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.6B |
| IPO Year | 2021 | N/A |
| Metric | APA | FMS |
|---|---|---|
| Price | $35.75 | $21.98 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 23 | 2 |
| Target Price | ★ $31.96 | $30.00 |
| AVG Volume (30 Days) | ★ 6.6M | 637.8K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 2.48% | ★ 2.57% |
| EPS Growth | ★ 75.77 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.86 | N/A |
| Revenue Next Year | N/A | $3.83 |
| P/E Ratio | ★ $9.05 | $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.15 | $20.02 |
| 52 Week High | $45.66 | $30.46 |
| Indicator | APA | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 40.63 | 46.48 |
| Support Level | $35.13 | $21.26 |
| Resistance Level | $45.66 | $23.89 |
| Average True Range (ATR) | 1.30 | 0.42 |
| MACD | -0.42 | -0.13 |
| Stochastic Oscillator | 7.51 | 56.43 |
APA Corp is an independent exploration and production company. It develops and produces crude oil, natural gas, and natural gas liquids. The company's business has oil and gas operations in four segments: Egypt, the North Sea, Suriname, and the U.S. The company generates the majority of its revenue from the U.S. reporting segment. The company also has exploration interests in Uruguay, Alaska, and other international locations.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.